VC
KURA icon

Voss Capital’s Kura Oncology KURA Stock Holding History

Voss Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,737
Closed -$309K – 63
2025
Q4 		$309K Sell
29,737
-275,922
-90% -$2.9M 0.01% 54
2025
Q3 		$2.71M Hold
305,659
– – 0.13% 43
2025
Q2 		$1.76M Buy
305,659
+55,659
+22% +$341K 0.12% 43
2025
Q1 		$1.65M Sell
250,000
-25,000
-9% -$195K 0.13% 45
2024
Q4 		$2.4M Buy
+275,000
New +$3.96M 0.18% 39

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voss Capital's KURA Position: Q1 2026 in Review

Voss Capital sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 29,737 shares — an estimated $309K sold.

Voss Capital first reported a position in KURA in Q4 2024 and held it in 5 quarters. The position peaked at $2.71M in Q3 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Voss Capital reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Voss Capital sold 29,737 Kura Oncology shares in Q1 2026, an estimated $309K.
  • Voss Capital first reported a position in Kura Oncology in Q4 2024 and held it in 5 quarters.
  • Voss Capital's Kura Oncology position peaked at $2.71M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Voss Capital's 13F filing for Q1 2026, filed 15 May 2026.